Chronic graft versus host disease (cGVHD) remains a major complication of allogeneic
hematopoietic stem cell transplantation (allo-HSCT). It significantly decreases survival and …

There are few established therapies for chronic graft-versus-host disease (cGVHD)
refractory to first-line treatment with steroids. We evaluated the efficacy and safety of …

Graft versus host disease (GvHD) is one of the most feared adverse events of allogeneic
hematopoietic stem cell transplantation. In severe grades of GvHD patients die from …

ABSTRACT Introduction Extracorporeal Photopheresis (ECP) may be considered the unique
large-scale cell therapy currently available. It is currently employed mainly as second-line …

BACKGROUND Steroid‐refractory acute graft‐versus‐host disease (aGVHD) is a serious
complication after hematopoietic stem cell transplantation. The long‐term outcome of the …

Background: Chronic graft-versus-host disease (cGVHD) can arise frequently as a late
complication after allogeneic hematopoietic cell transplantation. Patients with extensive …

Recent studies suggest that extracorporeal photochemotherapy (ECP) may be beneficial in
patients with steroid‐refractory chronic graft‐versus‐host disease (cGvHD). However, it is …

Over the last decades significant advances have been made in the field of donor selection,
alternative transplant sources, immunosuppressive treatment and supportive care, as well …

There are few prospective studies evaluating the role of extracorporeal photopheresis (ECP)
in chronic GVHD (cGVHD) and only occasional reports of the effect of ECP on patients' …

Despite significant advances in stem cell manipulation and post-transplant
immunosuppression, chronic graft-versus-host disease (cGVHD) remains a cause of major …